Analyst Viewpoint
Rise in prevalence of cancer is boosting the tumor ablation market size. Increase in awareness about cancer care is further fueling the demand for tumor ablation procedures. Radiofrequency ablation is gaining popularity as a critical cancer care technique for survival and pain management of patients.
Enhanced patient comfort, faster recovery time, and reduced procedure time are a few positive reasons why ablation therapy is gaining traction in the market. Prominent vendors operating in the global tumor ablation sector are investing significantly in R&D activities and partnerships to expand their product portfolio. Technological advancements in terms of improved accuracy, portability, and cost-effectiveness are likely to foster tumor ablation industry growth.
Tumor ablation is an image-guided, minimally intrusive surgery that aims to destroy cancer cells by exposure to either very cold or very hot temperatures. Ablation therapy is employed to treat cancer at its very source and also at a place where it metastasizes. According to World Health Organization (WHO), about 10-11 million people worldwide are expected to be diagnosed each year with cancer till 2030.
Tumor ablation utilizes advanced techniques such as radiofrequency, microwave ablation, and cryoablation to precisely act on the cancerous tissue while avoiding healthy tissue. Rise in global geriatric population and awareness of available cancer care are likely to propel market progress of the tumor ablation industry.
Liver cancer is the dominant segment of the tumor ablation industry based on disease indication. Lung cancer is also on the rise as air pollution worsens and the effects of long-term tobacco use become visible in older users.
Cancer is a globally prevalent disease and a leading cause of death worldwide. According to data publicly available by WHO, the disease accounts for nearly one in six deaths. WHO further mentions that cancer-causing infections such as hepatitis made up nearly one-third of cancer cases in the global South. A drastic increase in the global geriatric population and unhealthy modern lifestyles across age groups has worsened the prevalence of cancer.
Increase in expenditure on cancer care is augmenting the tumor ablation market revenue. In the U.S., National Cancer Institute forecasted that national estimates of cancer care costs are expected to rise to as high as US$ 173 Bn in 2020. Radiofrequency ablation technique is employed to treat tumors during early phase of their existence, which is critical for a patient’s survival and pain management.
Minimally invasive surgeries or therapies are hugely popular both with doctors and patients due to advantages such as faster recovery, enhanced patient comfort, and reduced procedure time. The ablative therapy industry post-pandemic has witnessed a surge in market statistics as awareness of healthcare products and services has increased.
Ablative therapies are employed primarily for smaller tumors, where precision is required. Advancement in tumor ablation devices and techniques such as utilization of image-guided equipment, internally cooled radiofrequency probes, and cryoablation are expected to offer lucrative opportunities for market expansion.
North America accounted for dominant tumor ablation market share in 2022. Presence of a well-developed healthcare sector, rise in awareness about upcoming cancer care technologies, and R&D of new care solutions are augmenting the market dynamics of the region.
According to the latest tumor ablation industry analysis, Europe is a lucrative market due to the availability of public healthcare and implementation of strict government laws regarding caregiving.
The tumor ablation market value is surging in developing countries such as China and India due to the strong presence of healthcare providers. Cancer welfare initiatives in the Asia Pacific region such as the Indian Government’s Health Minister’s Cancer Patient Fund (HMCPF) offers financial aid to patients in need. Efforts such as these are expected to foster a surge in usage of tumor ablation devices.
According to recent tumor ablation market trends, prominent manufacturers are investing substantially in the development of next-gen cancer therapy technologies. Close collaborations within the industry along with mergers and acquisitions are seen as key strategies to build a better product portfolio and maintain a strong position in the sector.
For example, in July 2021, Terumo Europe and University Medical Center Utrecht (UMC Utrecht) signed a Memorandum of Understanding (MoU) to collaborate on product development and technology transfer in the field of oncology. The move is expected to bring further developments to tumor ablation products in the near future.
Medtronic PLC, Integra LifeSciences Holdings Corpo. , BTG International Ltd, Boston Scientific Corporation, AngioDynamics Inc., SonaCare Medical LLC., BVM Medical Limited, St. Jude Medical, Inc., and EDAP TMS S.A. are key firms operating in this market.
These companies have been profiled in the tumor ablation market report based on various parameters such as company overview, business strategies, product portfolio, financial overview, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 1.3 Bn |
| Market Forecast Value in 2031 | US$ 2.3 Bn |
| Growth Rate (CAGR) | 6.9% |
| Forecast Period | 2023 to 2031 |
| Historical Data Available for | 2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 1.3 Bn in 2022
It is projected to grow at a CAGR of 6.9% from 2023 to 2031
Rise in prevalence of cancer and high demand for minimally invasive therapies
The radiofrequency ablation segment held the largest share in 2022
North America dominated the global landscape in 2022
Medtronic PLC, Integra LifeSciences Holdings Corporation , BTG International Ltd, Boston Scientific Corporation, AngioDynamics Inc., SonaCare Medical LLC., BVM Medical Limited, St. Jude Medical, Inc., and EDAP TMS S.A
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Tumor Ablation Market
4. Market Overview
4.1. Introduction
4.1.1. Technology, Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Tumor Ablation Market Analysis and Forecast, 2023–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Technology, /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Tumor Ablation Market Analysis and Forecast, by Technology,
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Technology, 2023–2031
6.3.1. Radiofrequency Ablation
6.3.2. Microwave Ablation
6.3.3. Cryoablation
6.3.4. High-Intensity Focused Ultrasound
6.3.5. Laser Interstitial Thermal Ablation
6.3.6. Others
6.4. Market Attractiveness Analysis, by Technology,
7. Tumor Ablation Market Analysis and Forecast, by Disease Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Disease Indication, 2023–2031
7.3.1. Liver Cancer
7.3.2. Lung Cancer
7.3.3. Kidney Cancer
7.3.4. Bone Cancer
7.3.5. Breast Cancer
7.3.6. Prostate Cancer
7.3.7. Others
7.4. Market Attractiveness Analysis, by Disease Indication
8. Tumor Ablation Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2023–2031
8.3.1. Home users
8.3.2. Clinics
8.3.3. Hospitals
8.4. Market Attractiveness Analysis, by Disease Indication
9. Tumor Ablation Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2023–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Tumor Ablation Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Technology, 2023–2031
10.3.1. Radiofrequency Ablation
10.3.2. Microwave Ablation
10.3.3. Cryoablation
10.3.4. High-Intensity Focused Ultrasound
10.3.5. Laser Interstitial Thermal Ablation
10.3.6. Others
10.4. Market Value Forecast, by Disease Indication, 2023–2031
10.4.1. Liver Cancer
10.4.2. Lung Cancer
10.4.3. Kidney Cancer
10.4.4. Bone Cancer
10.4.5. Breast Cancer
10.4.6. Prostate Cancer
10.4.7. Others
10.5. Market Value Forecast, by End-user, 2023–2031
10.5.1. Home users
10.5.2. Clinics
10.5.3. Hospitals
10.6. Market Value Forecast, by Country, 2023–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Technology,
10.7.2. By Disease Indication
10.7.3. By End-user
10.7.4. By Country
11. Europe Tumor Ablation Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Technology, 2023–2031
11.3.1. Radiofrequency Ablation
11.3.2. Microwave Ablation
11.3.3. Cryoablation
11.3.4. High-Intensity Focused Ultrasound
11.3.5. Laser Interstitial Thermal Ablation
11.3.6. Others
11.4. Market Value Forecast, by Disease Indication, 2023–2031
11.4.1. Liver Cancer
11.4.2. Lung Cancer
11.4.3. Kidney Cancer
11.4.4. Bone Cancer
11.4.5. Breast Cancer
11.4.6. Prostate Cancer
11.4.7. Others
11.5. Market Value Forecast, by End-user, 2023–2031
11.5.1. Home users
11.5.2. Clinics
11.5.3. Hospitals
11.6. Market Value Forecast, by Country/Sub-region, 2023–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Technology,
11.7.2. By Disease Indication
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Tumor Ablation Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Technology, 2023–2031
12.3.1. Radiofrequency Ablation
12.3.2. Microwave Ablation
12.3.3. Cryoablation
12.3.4. High-Intensity Focused Ultrasound
12.3.5. Laser Interstitial Thermal Ablation
12.3.6. Others
12.4. Market Value Forecast, by Disease Indication, 2023–2031
12.4.1. Liver Cancer
12.4.2. Lung Cancer
12.4.3. Kidney Cancer
12.4.4. Bone Cancer
12.4.5. Breast Cancer
12.4.6. Prostate Cancer
12.4.7. Others
12.5. Market Value Forecast, by End-user, 2023–2031
12.5.1. Home users
12.5.2. Clinics
12.5.3. Hospitals
12.6. Market Value Forecast, by Country/Sub-region, 2023–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Technology,
12.7.2. By Disease Indication
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Tumor Ablation Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Technology, 2023–2031
13.3.1. Radiofrequency Ablation
13.3.2. Microwave Ablation
13.3.3. Cryoablation
13.3.4. High-Intensity Focused Ultrasound
13.3.5. Laser Interstitial Thermal Ablation
13.3.6. Others
13.4. Market Value Forecast, by Disease Indication, 2023–2031
13.4.1. Liver Cancer
13.4.2. Lung Cancer
13.4.3. Kidney Cancer
13.4.4. Bone Cancer
13.4.5. Breast Cancer
13.4.6. Prostate Cancer
13.4.7. Others
13.5. Market Value Forecast, by End-user, 2023–2031
13.5.1. Home users
13.5.2. Clinics
13.5.3. Hospitals
13.6. Market Value Forecast, by Country/Sub-region, 2023–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Technology,
13.7.2. By Disease Indication
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Tumor Ablation Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Technology, 2023–2031
14.3.1. Radiofrequency Ablation
14.3.2. Microwave Ablation
14.3.3. Cryoablation
14.3.4. High-Intensity Focused Ultrasound
14.3.5. Laser Interstitial Thermal Ablation
14.3.6. Others
14.4. Market Value Forecast, by Disease Indication, 2023–2031
14.4.1. Liver Cancer
14.4.2. Lung Cancer
14.4.3. Kidney Cancer
14.4.4. Bone Cancer
14.4.5. Breast Cancer
14.4.6. Prostate Cancer
14.4.7. Others
14.5. Market Value Forecast, by End-user, 2023–2031
14.5.1. Home users
14.5.2. Clinics
14.5.3. Hospitals
14.6. Market Value Forecast, by Country/Sub-region, 2023–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Technology,
14.7.2. By Disease Indication
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Medtronic PLC
15.3.1.1. Company Overview
15.3.1.2. Technology, Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Integra LifeSciences Holdings Corporation
15.3.2.1. Company Overview
15.3.2.2. Technology, Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. BTG International Ltd.
15.3.3.1. Company Overview
15.3.3.2. Technology, Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Boston Scientific Corporation
15.3.4.1. Company Overview
15.3.4.2. Technology, Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. AngioDynamics Inc.
15.3.5.1. Company Overview
15.3.5.2. Technology, Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. SonaCare Medical LLC.
15.3.6.1. Company Overview
15.3.6.2. Technology, Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. BVM Medical Limited
15.3.7.1. Company Overview
15.3.7.2. Technology, Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. St. Jude Medical, Inc.
15.3.8.1. Company Overview
15.3.8.2. Technology, Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. EDAP TMS S.A
15.3.9.1. Company Overview
15.3.9.2. Technology, Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
List of Tables
Table 01: Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031
Table 02: Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 03: Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Table 04: Tumor Ablation Market Size (US$ Mn) Forecast, by Region, 2023–2031
Table 05: North America Tumor Ablation Market Size (US$ Mn) Forecast, by Country, 2023–2031
Table 06: North America Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031
Table 07: North America Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 08: North America Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Table 09: Europe Tumor Ablation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 10: Europe Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031
Table 11: Europe Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 12: Europe Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Table 13: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 14: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031
Table 15: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 16: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Table 17: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 18: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031
Table 19: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 20: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Table 21: Middle East & Africa Tumor Ablation Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 22: Middle East & Africa Tumor Ablation Market Size (US$ Mn) Forecast, by Technology, 2023–2031
Table 23: Middle East & Africa Tumor Ablation Market Size (US$ Mn) Forecast, by Disease Indication, 2023–2031
Table 24: Middle East & Africa Tumor Ablation Market Size (US$ Mn) Forecast, by End-user, 2023–2031
List of Figures
Figure 01: Tumor Ablation Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2031
Figure 02: Tumor Ablation Market Revenue (US$ Mn), by Technology, 2022
Figure 03: Tumor Ablation Market Value Share, by Technology, 2022
Figure 04: Tumor Ablation Market Revenue (US$ Mn), by Disease Indication, 2022
Figure 05: Tumor Ablation Market Value Share, by Disease Indication, 2022
Figure 06: Tumor Ablation Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Tumor Ablation Market Value Share, by End-user, 2022
Figure 08: Tumor Ablation Market Value Share, by Region, 2022
Figure 09: Tumor Ablation Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031
Figure 11: Tumor Ablation Market Attractiveness Analysis, by Technology, 2023-2031
Figure 12: Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031
Figure 13: Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023-2031
Figure 14: Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031
Figure 15: Tumor Ablation Market Attractiveness Analysis, by End-user, 2023-2031
Figure 16: Tumor Ablation Market Value Share Analysis, by Region, 2023 and 2031
Figure 17: Tumor Ablation Market Attractiveness Analysis, by Region, 2023-2031
Figure 18: North America Tumor Ablation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 19: North America Tumor Ablation Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Tumor Ablation Market Value Share Analysis, by Country, 2023 and 2031
Figure 21: North America Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031
Figure 22: North America Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031
Figure 23: North America Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031
Figure 24: North America Tumor Ablation Market Attractiveness Analysis, by Technology, 2023–2031
Figure 25: North America Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 26:North America Tumor Ablation Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Tumor Ablation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 28: Europe Tumor Ablation Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Tumor Ablation Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
Figure 30: Europe Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031
Figure 31: Europe Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031
Figure 32: Europe Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031
Figure 33: Europe Tumor Ablation Market Attractiveness Analysis, by Technology, 2023–2031
Figure 34: Europe Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 35: Europe Tumor Ablation Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Tumor Ablation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 37: Asia Pacific Tumor Ablation Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Tumor Ablation Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
Figure 39: Asia Pacific Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031
Figure 40: Asia Pacific Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031
Figure 41: Asia Pacific Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031
Figure 42: Asia Pacific Tumor Ablation Market Attractiveness Analysis, by Technology, 2023–2031
Figure 43: Asia Pacific Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 44: Asia Pacific Tumor Ablation Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Tumor Ablation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 46: Latin America Tumor Ablation Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Tumor Ablation Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
Figure 48: Latin America Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031
Figure 49: Latin America Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031
Figure 50: Latin America Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031
Figure 51: Latin America Tumor Ablation Market Attractiveness Analysis, by Technology, 2023–2031
Figure 52: Latin America Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 53: Latin America Tumor Ablation Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Tumor Ablation Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 55: Middle East & Africa Tumor Ablation Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Tumor Ablation Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
Figure 57: Middle East & Africa Tumor Ablation Market Value Share Analysis, by Technology, 2023 and 2031
Figure 58: Middle East & Africa Tumor Ablation Market Value Share Analysis, by Disease Indication, 2023 and 2031
Figure 59: Middle East & Africa Tumor Ablation Market Value Share Analysis, by End-user, 2023 and 2031
Figure 60: Middle East & Africa Tumor Ablation Market Attractiveness Analysis, by Technology, 2023–2031
Figure 61: Middle East & Africa Tumor Ablation Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 62: Middle East & Africa Tumor Ablation Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Tumor Ablation Market
